Baseline Interleukin‐10 Levels as a Predictive Biomarker for Achieving Clinical Response With Abatacept in Patients Who Were Disease‐Modifying Antirheumatic Drug Naive and Anti–Citrullinated Protein Antibody Positive With Early Rheumatoid Arthritis

Journal:

Arthritis & Rheumatology

Published:

2026-02-24

DOI:

10.1002/art.70106

Affiliations:

8

Authors:

15

Go to article

Institutions	Authors	Share
Bristol-Myers Squibb, United States of America (USA)	8.000000	0.53
PAREXEL International Corporation, United States of America (USA)	1.000000	0.07
NIHR Leeds Biomedical Research Centre, United Kingdom (UK)	1.000000	0.07
University of Occupational and Environmental Health (UOEH), Japan	1.000000	0.07
Hospital for Special Surgery (HSS), United States of America (USA)	1.000000	0.07
Johns Hopkins University (JHU), United States of America (USA)	1.000000	0.07
Leiden University Medical Center (LUMC), Netherlands	1.000000	0.07
The University of Texas Southwestern Medical Center (UT Southwestern Medical Center), United States of America (USA)	1.000000	0.07

Interested in Clinical Sciences?